To hear about similar clinical trials, please enter your email below
Trial Title:
Determining Patterns In Study Experiences of Neuroblastoma Patients
NCT ID:
NCT05918432
Condition:
Neuroblastoma
Conditions: Official terms:
Neuroblastoma
Conditions: Keywords:
Neuroblastoma
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Historically, participation in clinical research is highly skewed towards particular
demographic groups of people.
This study will invite several participants to gather a wide range of information on
clinical trial experiences for neuroblastoma patients. The aim of the study is to
identify the factors that limit the ability of a person to enroll in, as well as complete
a clinical trial for treatment of neuroblastoma.
The data collected from this study will help improve future outcomes for all
neuroblastoma patients as well as those in under-represented demographic groups.
Criteria for eligibility:
Study pop:
Patients with neuroblastoma who are actively considering enrolling in an interventional
clinical trial for said condition, but have not yet completed enrollment and
randomization phases in said clinical trial.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Confirmed diagnosis of neuroblastoma
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior
to participation in the study and any related procedures being performed
- Subjects willing and able to comply with the protocol for the duration of the study
including undergoing treatment and scheduled visits and examination.
Exclusion Criteria:
- Women of childbearing potential without a negative pregnancy test; or women who are
lactating.
- Any serious and/or unstable pre-existing medical disorders
- Enrolled in another research study
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Start date:
July 2024
Completion date:
July 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05918432
